Sign up
Healthed-White-on-Blue

Renal medicine

Kidney,Diseases.,Man,Suffering,From,Pain,With,Inflammation,And,Kidney
Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm
Podcasts iconPodcasts

Panel discussion on GLP1s for chronic kidney disease in type 2 diabetes

Advice and evidence for and role of GLP-1 receptor agonists in the prevention and management of kidney disease in patients with type 2 diabetes will be discussed.

Expert/s: Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm
2477166013
Prof Vlado Perkovic
Podcasts iconPodcasts

Rethinking CKD: From hidden risk to early intervention

Prof Vlado Perkovic outlines how early recognition and evidence-based treatment of CKD can prevent kidney failure and dramatically extend patient lives.

Expert/s: Prof Vlado Perkovic
Composition,Of,Hands,Holding,Kidneys,On,Green,Background,With,Copy
Dr Richard Phoon
Podcasts iconPodcasts

Chronic kidney disease – Delay progression and prevent dialysis

The evidence for the effectiveness of new drug options for chronic disease will be discussed, including when, how and in whom they should be prescribed to.

Expert/s: Dr Richard Phoon
Image_Andrew Sindone0
Prof Andrew Sindone
Videos iconVideos

Cardiorenal protection with dapagliflozin: An expert overview

In this Product Explainer, Cardiologist Prof Andrew Sindone explains the role of dapagliflozin in cardiorenal protection in patients with heart failure, chronic kidney disease and/or type 2 diabetes.

Expert/s: Prof Andrew Sindone
shutterstock_2477166013_Cropped
Dr Bobby Chan
Videos iconVideos

Preventing renal failure in type 2 diabetes – New options

Dr Bobby Chan presents the details of this new treatment for diabetes-related chronic kidney disease including, evidence and effectiveness

Expert/s: Dr Bobby Chan
Artboard 2
Sophia Auld
Clinical Articles iconClinical Articles

Managing CKD with co-existing conditions

Practical tips from the updated Handbook...

Expert/s: Sophia Auld
kidney(2222)
Sophia Auld
Clinical Articles iconClinical Articles

CKD medical management – key updates

PBS-listed drugs for CKD can slow deterioration by years, but early diagnosis is paramount...

Expert/s: Sophia Auld
Illustration,Of,Liver,On,Woman's,Body,Against,Gray,Background,,Hepatitis,
Dr Ronald Castelino
Podcasts iconPodcasts

DOAC dosing in special situations – Renal impairment, liver disease and obesity

Inappropriate DOAC dosing is a common problem- recognise which patients require reduced dosage, what GPs can do to optimise the dosage in view of the specific clinical characteristics of each patient.

Expert/s: Dr Ronald Castelino

Education by clinicians, for clinicians

Get the app

Site

Company

Connect

Legal

Discover

Healthed

CPD platform